{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:53:40Z","timestamp":1791914020994,"version":"4.3.4"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R21CA259985"],"award-info":[{"award-number":["1R21CA259985"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016058"],"award-info":[{"award-number":["P30CA016058"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01 CA215151"],"award-info":[{"award-number":["1R01 CA215151"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1K76AG074923"],"award-info":[{"award-number":["1K76AG074923"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Tumor genomic testing (TGT) is standard-of-care for most patients with advanced\/metastatic cancer. Despite established guidelines, patient education prior to TGT is frequently omitted. The purpose of this study was to evaluate the impact and durability of a concise 3\u20134 minute video for patient education prior to TGT in community versus academic sites and across cancer types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Patients undergoing standard-of-care TGT were enrolled at a tertiary academic institution in three cohorts: Cohort 1-breast cancer; Cohort 2-lung cancer; Cohort 3-other cancers. Cohort 4 consisted of patients with any cancer type similarly undergoing SOC TGT at one of three community cancer centers. Participants completed survey measures prior to video viewing (T1), immediately post-viewing (T2), and after return of TGT results (T3). Outcome measures included: 1) 10-question objective genomic knowledge\/understanding (GKU); 2) 10-question video message-specific knowledge (VMSK); 3) 11-question Trust in Physician\/Provider (TIPP); 4) perceptions regarding TGT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 203 participants completed all survey timepoints. Higher baseline GKU and VMSK scores were significantly associated with higher income and greater years of education. For the primary objective, there was a significant and sustained improvement in VMSK from T1:T2:T3 (P\n                      <jats:sub>overall<\/jats:sub>\n                      p\u2009&lt;\u20090.0001), with no significant change in GKU (p\u2009=\u20090.41) or TIPP (p\u2009=\u20090.73). This trend was consistent within each cohort (all p\u2009\u2264\u20090.0001). Results for four VMSK questions significantly improved, including impact on treatment decisions, incidental germline findings, and insurance coverage of testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A concise, 3\u20134 minute, broadly applicable educational video administered prior to TGT significantly and sustainably improved video message-specific knowledge in diverse cancer types and in academic and community settings. This resource is publicly available at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.tumor-testing.com\" xlink:type=\"simple\">http:\/\/www.tumor-testing.com<\/jats:ext-link>\n                      , with a goal to efficiently educate and empower patients regarding TGT while addressing guidelines within the flow of clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05215769\" xlink:type=\"simple\">NCT05215769<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0360611","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:31:58Z","timestamp":1791912718000},"page":"e0360611","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of a concise video to improve patient understanding of tumor genomic testing in community and academic practice settings"],"prefix":"10.1371","volume":"21","author":[{"given":"Deloris J.","family":"Veney","sequence":"first","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center","place":["Columbus, Ohio, United States of America"],"department":["Division of Medical Oncology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[{"name":"The Ohio State University","place":["Columbus, Ohio, United States of America"],"department":["Department of Biomedical Informatics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaden","family":"Miller","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center","place":["Columbus, Ohio, United States of America"],"department":["Division of Human Genetics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda E.","family":"Toland","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center","place":["Columbus, Ohio, United States of America"],"department":["Division of Human Genetics"]},{"name":"The Ohio State University","place":["Columbus, Ohio, United States of America"],"department":["Department of Cancer Biology and Genetics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2607-5639","authenticated-orcid":true,"given":"Carolyn J.","family":"Presley","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center","place":["Columbus, Ohio, United States of America"],"department":["Division of Medical Oncology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7558-9794","authenticated-orcid":true,"given":"Heather","family":"Hampel","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center","place":["Duarte, California, United States of America"],"department":["Division of Clinical Cancer Genomics, Department of Medical Oncology and Therapeutics Research"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6644-8084","authenticated-orcid":true,"given":"Tasleem J.","family":"Padamsee","sequence":"additional","affiliation":[{"name":"College of Public Health, The Ohio State University","place":["Columbus, Ohio, United States of America"],"department":["Division of Health Services Management and Policy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Bon Secours-Mercy Health Lima","place":["Lima, Ohio, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Bon Secours-Mercy Health St. Elizabeth","place":["Youngstown, Ohio, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly R.","family":"Hovick","sequence":"additional","affiliation":[{"name":"School of Communication, The Ohio State University","place":["Columbus, Ohio, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Irvin","sequence":"additional","affiliation":[{"name":"Bon Secours Cancer Institute at St. Francis","place":["Richmond, Virginia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigha","family":"Senter","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center","place":["Columbus, Ohio, United States of America"],"department":["Division of Human Genetics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9003-8165","authenticated-orcid":true,"given":"Daniel G.","family":"Stover","sequence":"additional","affiliation":[{"name":"The Ohio State University Comprehensive Cancer Center","place":["Columbus, Ohio, United States of America"],"department":["Division of Medical Oncology"]},{"name":"The Ohio State University","place":["Columbus, Ohio, United States of America"],"department":["Department of Biomedical Informatics"]},{"name":"Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer","place":["Columbus, Ohio, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"issue":"8","key":"pone.0360611.ref001","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41576-021-00338-8","article-title":"Clinical cancer genomic profiling","volume":"22","author":"D Chakravarty","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"11","key":"pone.0360611.ref002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.6004\/jnccn.2025.7063","article-title":"Molecular biomarker testing patterns and turnaround time in US patients with advanced non-small cell lung cancer","volume":"23","author":"X Wang","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"pone.0360611.ref003","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ejhg.2013.158","article-title":"Testing personalized medicine: Patient and physician expectations of next-generation genomic sequencing in late-stage cancer care","volume":"22","author":"FA Miller","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"pone.0360611.ref004","article-title":"Prospective decision analysis study of clinical genomic testing in metastatic breast cancer: Impact on outcomes and patient perceptions","volume":"3","author":"DG Stover","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"pone.0360611.ref005","article-title":"Medical oncologists\u2019 Experiences in using genomic testing for lung and colorectal cancer care","volume":"13","author":"SW Gray","year":"2017","journal-title":"J Oncol Pract"},{"issue":"10","key":"pone.0360611.ref006","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/gim.2015.207","article-title":"Oncologists\u2019 and cancer patients\u2019 views on whole-exome sequencing and incidental findings: results from the CanSeq study","volume":"18","author":"SW Gray","year":"2016","journal-title":"Genet Med"},{"issue":"1","key":"pone.0360611.ref007","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12885-020-06905-2","article-title":"Metastatic breast cancer patient perceptions of somatic tumor genomic testing","volume":"20","author":"EJ Adams","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"pone.0360611.ref008","doi-asserted-by":"crossref","DOI":"10.1200\/OP.22.00316","article-title":"Patient Understanding of Tumor Genomic Testing: A Quality Improvement Effort","volume":"19","author":"L Senter","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"17","key":"pone.0360611.ref009","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70095","article-title":"A video intervention to improve patient understanding of tumor genomic testing in patients with cancer","volume":"13","author":"DJ Veney","year":"2024","journal-title":"Cancer Med"},{"key":"pone.0360611.ref010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1200\/PO.21.00109","article-title":"Distribution of genomic testing resources by oncology practice and rurality: a nationally representative study","volume":"5","author":"B Gardner","year":"2021","journal-title":"JCO Precision Oncol"},{"issue":"21","key":"pone.0360611.ref011","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2217\/fon-2019-0010","article-title":"Utilization of tumor genomics in clinical practice: an international survey among ASCO members","volume":"15","author":"R Barroso-Sousa","year":"2019","journal-title":"Future Oncol"},{"key":"pone.0360611.ref012","article-title":"Oncologist-reported reasons for not ordering multimarker tumor panels: Results From a nationally representative survey","volume":"5","author":"MC Roberts","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"pone.0360611.ref013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10897-017-0134-3","article-title":"Physician experiences and understanding of genomic sequencing in oncology","volume":"27","author":"CM Weipert","year":"2018","journal-title":"J Genet Couns"},{"issue":"27","key":"pone.0360611.ref014","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1200\/JCO.2017.74.1744","article-title":"Identifying health information technology needs of oncologists to facilitate the adoption of genomic medicine: Recommendations from the 2016 American society of clinical oncology omics and precision oncology workshop","volume":"35","author":"KS Hughes","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"pone.0360611.ref015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.11137","article-title":"Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing","volume":"318","author":"D Mandelker","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"pone.0360611.ref016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19452","article-title":"Yield and utility of germline testing following tumor sequencing in patients with cancer","volume":"3","author":"SE Lincoln","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0360611.ref017","article-title":"Decision-making preferences about secondary germline findings that arise from tumor genomic profiling among patients with advanced cancers","volume":"1","author":"JG Hamilton","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"pone.0360611.ref018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.28966","article-title":"Attitudes toward molecular testing for personalized cancer therapy","volume":"121","author":"RA Yusuf","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"pone.0360611.ref019","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/cge.12618","article-title":"Measuring genetic knowledge: A brief survey instrument for adolescents and adults","volume":"89","author":"SM Fitzgerald-Butt","year":"2016","journal-title":"Clin Genet"},{"key":"pone.0360611.ref020","first-page":"1091","article-title":"Development of the Trust in Physician scale: A measure to assess interpersonal trust in patient-physician relationships","volume":"67","author":"LA Anderson","year":"1990","journal-title":"Psychol Rep"},{"key":"pone.0360611.ref021","doi-asserted-by":"crossref","DOI":"10.1006\/enrs.1998.3940","article-title":"Proposed model of the relationship of risk information seeking and processing to the development of preventive behaviors","volume":"80","author":"RJ Griffin","year":"1999","journal-title":"Environ Res"},{"issue":"8","key":"pone.0360611.ref022","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/annonc\/mdz136","article-title":"Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group","volume":"30","author":"D Mandelker","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"pone.0360611.ref023","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/cncr.34063","article-title":"A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN cancer research group (EAQ152)","volume":"128","author":"AR Bradbury","year":"2022","journal-title":"Cancer"},{"key":"pone.0360611.ref024","volume-title":"Community engagement: a health promotion guide for universal health coverage in the hands of the people","author":"WH Organization","year":"2020"},{"issue":"31","key":"pone.0360611.ref025","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility","volume":"33","author":"ME Robson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"pone.0360611.ref026","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JOP.19.00201","article-title":"When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing","volume":"15","author":"K DeLeonardis","year":"2019","journal-title":"J Oncol Practice"},{"issue":"1","key":"pone.0360611.ref027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: Genetic\/familial high-risk assessment: Breast and Ovarian, Version 2.2017","volume":"15","author":"MB Daly","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"pone.0360611.ref028","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"RC Green","year":"2013","journal-title":"Genet Med"},{"issue":"1","key":"pone.0360611.ref029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A joint consensus recommendation of the association for molecular pathology, American society of clinical oncology, and college of American pathologists","volume":"19","author":"MM Li","year":"2017","journal-title":"J Mol Diagn"},{"issue":"31","key":"pone.0360611.ref030","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American society of clinical oncology policy statement Update: Genetic and genomic testing for cancer susceptibility","volume":"33","author":"ME Robson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"pone.0360611.ref031","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41436-020-0783-8","article-title":"Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"MM Li","year":"2020","journal-title":"Genet Med"},{"key":"pone.0360611.ref032","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2025.06.011","article-title":"Missed opportunities: Germline testing following tumor sequencing","volume":"199","author":"HC Karpel","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"3","key":"pone.0360611.ref033","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pec.2010.12.005","article-title":"How much does trust really matter? A study of the longitudinal effects of trust and decision-making preferences on diabetic patient outcomes","volume":"85","author":"Y-Y Lee","year":"2011","journal-title":"Patient Educ Couns"},{"issue":"3","key":"pone.0360611.ref034","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: A self-report depression scale for research in the general population","volume":"1","author":"LS Radloff","year":"1977","journal-title":"Applied Psychol Measurement"},{"issue":"6","key":"pone.0360611.ref035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"AT Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"pone.0360611.ref036","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaoncol.2020.0016","article-title":"The ethics of delivering precision medicine-pretest counseling and somatic genomic testing","volume":"6","author":"HT Borno","year":"2020","journal-title":"JAMA Oncol"},{"issue":"3","key":"pone.0360611.ref037","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pec.2004.09.005","article-title":"Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer)","volume":"57","author":"MS Wolf","year":"2005","journal-title":"Patient Educ Couns"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:32:05Z","timestamp":1791912725000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0360611"}},"subtitle":[],"editor":[{"given":"Kokouvi","family":"Kassegne","sequence":"first","affiliation":[{"name":"Shanghai Jiao Tong University School of Medicine","place":["CHINA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0360611","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}